In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil.
The human eye — though one of the body’s most complex and intricate structures — happens to be an ideal early candidate for treatments that incorporate CRISPR, the Nobel Prize-winning tool that may help precisely target and alter sequences of DNA associated with disease.
Read the full article by Brian Mattmiller at Morgridge Institute for Research
